Exploration of a Novel Prognostic Nomogram and Diagnostic Biomarkers Based on the Activity Variations of Hallmark Gene Sets in Hepatocellular Carcinoma

Abstract

BackgroundThe initiation and progression of tumors were due to variations of gene sets rather than individual genes. This study aimed to identify novel biomarkers based on gene set variation analysis (GSVA) in hepatocellular carcinoma.MethodsThe activities of 50 hallmark pathways were scored in three microarray datasets with paired samples with GSVA, and differential analysis was performed with the limma R package. Unsupervised clustering was conducted to determine subtypes with the ConsensusClusterPlus R package in the TCGA-LIHC (n = 329) and LIRI-JP (n = 232) cohorts. Differentially expressed genes among subtypes were identified as initial variables. Then, we used TCGA-LIHC as the training set and LIRI-JP as the validation set. A six-gene model calculating the risk scores of patients was integrated with the least absolute shrinkage and selection operator (LASSO) and stepwise regression analyses. Kaplan–Meier (KM) and receiver operating characteristic (ROC) curves were performed to assess predictive performances. Multivariate Cox regression analyses were implemented to select independent prognostic factors, and a prognostic nomogram was integrated. Moreover, the diagnostic values of six genes were explored with the ROC curves and immunohistochemistry.ResultsPatients could be separated into two subtypes with different prognoses in both cohorts based on the identified differential hallmark pathways. Six prognostic genes (ASF1A, CENPA, LDHA, PSMB2, SRPRB, UCK2) were included in the risk score signature, which was demonstrated to be an independent prognostic factor. A nomogram including 540 patients was further integrated and well-calibrated. ROC analyses in the five cohorts and immunohistochemistry experiments in solid tissues indicated that CENPA and UCK2 exhibited high and robust diagnostic values.ConclusionsOur study explored a promising prognostic nomogram and diagnostic biomarkers in hepatocellular carcinoma.

Identification and validation of a prognostic model based on four genes related to satellite nodules in hepatocellular carcinoma

“…Within the realm of HCC, SRPRB has been integrated into several prognostic models, including those grounded in endoplasmic reticulum stress-related genes and the activity fluctuations of hallmark genes. 38 , 39 . Nevertheless, the precise biological role of SRPRB in the context of HCC necessitates further exploration and investigation.…”

Construction and evaluation of an aging-associated genes-based model for pancreatic adenocarcinoma prognosis and therapies

“…Based on the expression level of aging-associated genes, the “pam” algorithm and “Pearson” was used from the ConsensusClusterPlus software (version 1.54.0) as length distance, 33 and 500 bootstraps were performed. The number of clusters was set as 2–10, and three subtypes were identified using R3.6.1.…”

Single‐cell transcriptome landscape elucidates the cellular and developmental responses to tomato chlorosis virus infection in tomato leaf

“…GSVA converts the gene expression matrix of different samples/cell populations into the gene expression matrix among them to evaluate whether different metabolic pathways are enriched in different samples/cell populations (Zhong et al, 2022). The rank statistics calculation, similar to the KS test, was performed for the gene set corresponding to each pathway, and the expression matrix was converted into a pathway enrichment score matrix; the GSVA enrichment score was obtained for each cell corresponding to each pathway.…”